체외식 제세동기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

External Defibrillators Market Growth & Trends:

The global external defibrillators market size is anticipated to reach USD 6.71 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 9.7% from 2024 to 2030. The key factors driving the market growth include rising technological advancements, initiatives for promoting public access AEDs, and the incidence of sudden cardiac arrest. The COVID-19 pandemic increased awareness about defibrillation training and the use of external defibrillators in case of an adverse cardiac event, thus increasing demand for defibrillators. The pandemic also resulted in logistical bottlenecks and operational challenges.

According to the study published in Elsevier, Inc., the number of out-of-hospital cardiac arrests occurring in Paris and its suburbs almost doubled amid the pandemic, from March 16 to April 26, 2020. Such factors are expected to boost sales of external defibrillators. In addition, the International Liaison Committee on Cardiopulmonary Resuscitation (ILCOR) changed the resuscitation guidelines. The new rules suggested improving defibrillation delivery by providing training to healthcare workers, which can reduce confusion as well as the delay in COVID-19 resuscitation efforts. The training would also ensure that healthcare providers are not exposed to additional risks and patients suffering from tachyarrhythmia arrests can be provided the best chance of survival.

Increasing prevalence of the cardiovascular disease is a major driver for market growth. According to the WHO, in 2019, 17.9 million deaths occurred due to cardiovascular disease, which was estimated around 32% globally. Moreover, more than 75% of deaths occurred in middle- & low-income countries. According to American Heart Association, 390,000 sudden cardiac arrests were reported in 2018. Out of these, 65% of deaths occurred in people aged 75 & above, 6% deaths in the age group of 25 to 54 years, and 29% in the age group of 55 to 74 years. Owing to these factors, the demand for external defibrillators is anticipated to increase over the forecast period.

Despite developments in prevention and treatment, sudden cardiac death remains a leading cause of mortality and is accountable for nearly half of all deaths from cardiovascular ailments. The increasing prevalence of SCA and its associated risk factors are expected to increase the demand for AEDs. SCA is one of the leading causes of death around the globe. Moreover, it is the major cause of natural deaths in the U.S., resulting in about 325,000 adult deaths in the country every year. SCA is also responsible for half of all heart ailment deaths.

External Defibrillators Market Report Highlights:

• The market was valued at USD 3.51 billion in 2023 and is expected to expand at a CAGR of 9.7% during the forecast period
• The manual external defibrillators segment held the largest revenue share of the market in 2023
• The end-use segment, on the other hand, was dominated by hospitals as these register the highest patient volume thus requiring defibrillators as part of their cardiology units
• North America dominated the market in 2023 due to the presence of key players and growing strategic initiatives deployed by these companies
• For instance, in April 2019 Stryker launched LIFEPAK CR2 AED in the U.S., expanding its lineup of defibrillation solutions. The product connects to an AED program manager, LIFELINKcentral, to help an organization's AED manager to monitor and manage device readiness issues remotely. When connected to Wi-Fi, the device also provides near real-time email alerts
• Obesity and hypertension are also risk factors for SCA. Obesity continues to be a significant public health crisis. According to a study published online in Pediatrics, obesity rates among children significantly increased during the first few months of the COVID-19 pandemic
• Around 80.0% of sudden cardiac deaths are linked to coronary heart disease. It is the most common type of heart disease, and as per CDC, approximately 18.2 million adults aged 20 and older suffer from this disease. Thus, AEDs are important because they increase the chance of survival. They can restore a normal heart rhythm in sudden cardiac arrest victims

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
  • 1.2.1. Information Procurement
• 1.3. Information or Data Analysis
• 1.4. Methodology
• 1.5. Research Scope and Assumptions
• 1.6. Market Formulation & Validation
  • 1.6.1. Country Market: Cagr Calculation
• 1.7. Country Based Segment Share Calculation
• 1.8. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional Insights
• 2.4. Competitive Insights
• 2.5. External Defibrillators Market Snapshot
• 2.6. External Defibrillators Market Segment Snapshot
• 2.7. External Defibrillators Market Competitive Landscape Snapshot

Chapter 3. External Defibrillators Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological advancements
    • 3.2.1.2. Growing government initiatives for installation of AEDs in public places
    • 3.2.1.3. Increasing incidence rate of SCA
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of awareness
    • 3.2.2.2. Product Recalls
• 3.3. External Defibrillators Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
• 3.4. Impact of COVID-19 on External Defibrillators Market

Chapter 4. External Defibrillators Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. External Defibrillators Market: Product Movement Analysis, USD Million, 2023 & 2030
• 4.3. Manual External Defibrillators
  • 4.3.1. Manual External Defibrillators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Automated External Defibrillators
  • 4.4.1. Automated External Defibrillators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Semi-Automated ED
    • 4.4.2.1. Semi-Automated ED Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Fully Automated ED
    • 4.4.3.1. Fully Automated ED Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Wearable Cardioverter Defibrillators
  • 4.5.1. Wearable Cardioverter Defibrillators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. External Defibrillators Market: End-use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. External Defibrillators Market: End-use Movement Analysis, USD Million, 2023 & 2030
• 5.3. Hospital
  • 5.3.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Pre-hospital
  • 5.4.1. Pre-hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Public Access Market
  • 5.5.1. Public Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Alternate Care Market
  • 5.6.1. Alternate Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Home Healthcare
  • 5.7.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. External Defibrillators Market: Regional Estimates & Trend Analysis

• 6.1. External Defibrillators Market: Regional Movement Analysis, 2023 & 2030
• 6.2. North America
  • 6.2.1. North America External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Prevalence Insights
    • 6.2.2.3. Regulatory Framework
    • 6.2.2.4. Reimbursement Structure
    • 6.2.2.5. U.S. External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Prevalence Insights
    • 6.2.3.3. Regulatory Framework
    • 6.2.3.4. Reimbursement Structure
    • 6.2.3.5. Canada External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Prevalence Insights
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. Reimbursement Structure
    • 6.3.2.5. UK External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Prevalence Insights
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Reimbursement Structure
    • 6.3.3.5. Germany External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Prevalence Insights
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. Reimbursement Structure
    • 6.3.4.5. France External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Prevalence Insights
    • 6.3.5.3. Regulatory Framework
    • 6.3.5.4. Reimbursement Structure
    • 6.3.5.5. Italy External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Prevalence Insights
    • 6.3.6.3. Regulatory Framework
    • 6.3.6.4. Reimbursement Structure
    • 6.3.6.5. Spain External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Prevalence Insights
    • 6.3.7.3. Regulatory Framework
    • 6.3.7.4. Reimbursement Structure
    • 6.3.7.5. Denmark External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Prevalence Insights
    • 6.3.8.3. Regulatory Framework
    • 6.3.8.4. Reimbursement Structure
    • 6.3.8.5. Sweden External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Prevalence Insights
    • 6.3.9.3. Regulatory Framework
    • 6.3.9.4. Reimbursement Structure
    • 6.3.9.5. Norway External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Prevalence Insights
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. Reimbursement Structure
    • 6.4.2.5. Japan External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Prevalence Insights
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Reimbursement Structure
    • 6.4.3.5. China External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Prevalence Insights
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. Reimbursement Structure
    • 6.4.4.5. India External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. South Korea
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Prevalence Insights
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Reimbursement Structure
    • 6.4.5.5. South Korea External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Australia
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Prevalence Insights
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Reimbursement Structure
    • 6.4.6.5. Australia External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Prevalence Insights
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. Reimbursement Structure
    • 6.4.7.5. Thailand External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Prevalence Insights
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement Structure
    • 6.5.2.5. Brazil External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Prevalence Insights
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement Structure
    • 6.5.3.5. Mexico External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Argentina
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Prevalence Insights
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement Structure
    • 6.5.4.5. Argentina External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East & Africa
  • 6.6.1. Middle East & Africa External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Prevalence Insights
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement Structure
    • 6.6.2.5. South Africa External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Prevalence Insights
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement Structure
    • 6.6.3.5. Saudi Arabia External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Prevalence Insights
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement Structure
    • 6.6.4.5. UAE External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Prevalence Insights
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement Structure
    • 6.6.5.5. Kuwait External Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Company Market Share Analysis, 2023
• 7.3. Strategy Mapping
• 7.4. Company Profiles/Listing
  • 7.4.1. Koninklijke Philips N.V.
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance (Net Revenue)
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Stryker
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance (Net Revenue)
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. ZOLL Medical Corporation
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance (Net Revenue)
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Nihon Kohden Corporation
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance (Net Revenue)
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Progetti Srl
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance (Net Revenue)
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Schiller AG
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance (Net Revenue)
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. MS Westfalia GmbH
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance (Net Revenue)
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. AMI Italia
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance (Net Revenue)
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Bexen Cardio
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance (Net Revenue)
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Silverline Meditech Pvt. Ltd.
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance (Net Revenue)
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives
  • 7.4.11. Mediana Co., Ltd.
    • 7.4.11.1. Overview
    • 7.4.11.2. Financial Performance (Net Revenue)
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Strategic Initiatives
  • 7.4.12. Shenzhen Mindray Bio-Medical Electronics
    • 7.4.12.1. Overview
    • 7.4.12.2. Financial Performance (Net Revenue)
    • 7.4.12.3. Product Benchmarking
    • 7.4.12.4. Strategic Initiatives
  • 7.4.13. CU Medical
    • 7.4.13.1. Overview
    • 7.4.13.2. Financial Performance (Net Revenue)
    • 7.4.13.3. Product Benchmarking
    • 7.4.13.4. Strategic Initiatives
  • 7.4.14. Medical Technologies
    • 7.4.14.1. Overview
    • 7.4.14.2. Financial Performance (Net Revenue)
    • 7.4.14.3. Product Benchmarking
    • 7.4.14.4. Strategic Initiatives
  • 7.4.15. Corpuls
    • 7.4.15.1. Overview
    • 7.4.15.2. Financial Performance (Net Revenue)
    • 7.4.15.3. Product Benchmarking
    • 7.4.15.4. Strategic Initiatives